Interaction of chemically modified antisense oligonucleotides with sense DNA: A label-free interaction study with reflectometric interference spectroscopy
M. Sauer et al., Interaction of chemically modified antisense oligonucleotides with sense DNA: A label-free interaction study with reflectometric interference spectroscopy, ANALYT CHEM, 71(14), 1999, pp. 2850-2857
Antisense oligonucleotides (ON) are regarded as potential therapeutic agent
s for controlling gene expression at the mRNA level. The strength of the in
teraction with the target sequence is one critical factor for the therapeut
ic efficiency of an ON. Herein, the results of studies on antisense 15mer a
nd 20mer ONs against mdr1b-mRNA are described. The mdr1b is a member of the
group that encodes the P-glycoprotein (Pgp), responsible for the phenomeno
n of multidrug resistance. The effects of backbone modification (DNA, phosp
horothioate (PTO)), terminal modifications (hexadecyl, cholesteryl, tocophe
rol, polyethylenglycol, 2'-O-methyl-modified RNA) and base sequence misalig
nments (1 to 3 bases) on interaction kinetics and binding strength were inv
estigated. The interaction of an immobilized sense strand with the dissolve
d antisense ON was monitored with a label-free optical transducer based on
thin film interference (RIfS), Association kinetics were detected at a low
density of immobilized ON. Thermodynamics were investigated by homogeneous
phase titration of sense and antisense ON and subsequent quantification of
equilibrium concentrations of unbound ON at a transducer highly loaded with
sense ON. Association rate constants varied from 3.1 (+/-0.2) x 10(4) M-1
s(-1) (poly(ethylene glycol)-modified DNA strand) to 4.3 (+/-0.1) x 10(4) M
-1 s(-1) (hexadecyl-modified strand). Binding constants varied from 1.9 (+/
- 0.1) x 10(8) M-1 (cholesteryl modification) to 5 (+/-0.4) x 10(7) M-1 (to
copherol modification). Phosphorothioate ON showed a reduction in binding s
trength of more than 1 order of magnitude. The data presented give valuable
information for the efficiency of modified antisense oligonucleotides.